Gene · 9113
Papers3,081
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,561 to 1,580 of 3,081
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Emerging Roles of Long non-coding RNAs in The Tumor Microenvironment. | Int J Biol Sci | 2020 | 32549757 | PubTator, text mining | PubMed |
| Hsa_circ_0085576 promotes clear cell renal cell carcinoma tumorigenesis and metastasis through the miR-498/YAP1 axis. | Aging (Albany NY) | 2020 | 32541093 | PubTator, text mining | PubMed |
| The Non-coding Side of Medulloblastoma. | Front Cell Dev Biol | 2020 | 32528946 | PubTator, text mining | PubMed |
| Prenatal exposure to bisphenol A alters the transcriptome-interactome profiles of genes associated with Alzheimer's disease in the offspring hippocampus. | Sci Rep | 2020 | 32528016 | PubTator, text mining | PubMed |
| SASH1 suppresses triple-negative breast cancer cell invasion through YAP-ARHGAP42-actin axis. | Oncogene | 2020 | 32523092 | PubTator, text mining | PubMed |
| O-GlcNAcylation on LATS2 disrupts the Hippo pathway by inhibiting its activity. | Proc Natl Acad Sci U S A | 2020 | 32513743 | PubTator, text mining | PubMed |
| Long noncoding RNA MSC-AS1 promotes hepatocellular carcinoma oncogenesis via inducing the expression of phosphoglycerate kinase 1. | Cancer Med | 2020 | 32489020 | PubTator, text mining | PubMed |
| BAG3 Pro209 mutants associated with myopathy and neuropathy relocate chaperones of the CASA-complex to aggresomes. | Sci Rep | 2020 | 32472079 | PubTator, text mining | PubMed |
| A Systematic Literature Review of Whole Exome and Genome Sequencing Population Studies of Genetic Susceptibility to Cancer. | Cancer Epidemiol Biomarkers Prev | 2020 | 32467344 | PubTator, text mining | PubMed |
| The Crosstalk between Src and Hippo/YAP Signaling Pathways in Non-Small Cell Lung Cancer (NSCLC). | Cancers (Basel) | 2020 | 32466572 | PubTator, text mining | PubMed |
| Genomic and Transcriptomic Characteristics According to Size of Papillary Thyroid Microcarcinoma. | Cancers (Basel) | 2020 | 32466217 | PubTator, text mining | PubMed |
| Long non-coding RNAs towards precision medicine in gastric cancer: early diagnosis, treatment, and drug resistance. | Mol Cancer | 2020 | 32460771 | PubTator, text mining | PubMed |
| SPOP promotes ubiquitination and degradation of LATS1 to enhance kidney cancer progression. | EBioMedicine | 2020 | 32460168 | PubTator, text mining | PubMed |
| The Genomic Characteristics of ALK Fusion Positive Tumors in Chinese NSCLC Patients. | Front Oncol | 2020 | 32457845 | PubTator, text mining | PubMed |
| p190A inactivating mutations cause aberrant RhoA activation and promote malignant transformation via the Hippo-YAP pathway in endometrial cancer. | Signal Transduct Target Ther | 2020 | 32457342 | PubTator, text mining | PubMed |
| Emerging agents that target signaling pathways in cancer stem cells. | J Hematol Oncol | 2020 | 32456660 | PubTator, text mining | PubMed |
| WWC1 and NF2 Prevent the Development of Intrahepatic Cholangiocarcinoma by Regulating YAP/TAZ Activity through LATS in Mice. | Mol Cells | 2020 | 32451369 | PubTator, text mining | PubMed |
| SHCBP1 promotes tumor cell proliferation, migration, and invasion, and is associated with poor prostate cancer prognosis. | J Cancer Res Clin Oncol | 2020 | 32447485 | PubTator, text mining | PubMed |
| PLOD1, a target of miR-34c, contributes to cell growth and metastasis via repressing LATS1 phosphorylation and inactivating Hippo pathway in osteosarcoma. | Biochem Biophys Res Commun | 2020 | 32446383 | PubTator, text mining | PubMed |
| Regulation and functions of the Hippo pathway in stemness and differentiation. | Acta Biochim Biophys Sin (Shanghai) | 2020 | 32445460 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9113/papers?page=79